endpoint and Berlinger Collaborate to Provide Complete Visibility of the Historical Temperature Journey of an IMP
PR92155
SAN FRANCISCO and SWITZERLAND, Oct. 7, 2021 /PRNewswire=KYODO JBN/ --
-- Fully integrated solution: Turn a 25-day manual temperature-monitoring data
evaluation into instant decision making
endpoint Clinical (https://c212.net/c/link/?t=0&l=en&o=3314794-1&h=2358724327&u=https%3A%2F%2Fwww.endpointclinical.com%2Firt-solution%2F&a=endpoint+Clinical), the leader in global interactive response
technology (IRT(R)) for clinical trials, and Berlinger & Co. AG (https://c212.net/c/link/?t=0&l=en&o=3314794-1&h=3294264099&u=https%3A%2F%2Fwww.berlinger.com%2Fusa%2F&a=Berlinger+%26+Co.+AG%2C), specializing in the production of innovative and customized solutions for
monitoring temperature-sensitive goods in the pharmaceutical and medical
industry, have announced their partnership to provide complete end to end
visibility of the entire temperature history of an Investigational Medicinal
Product (IMP).
Logo - https://mma.prnewswire.com/media/1654012/endpoint_Logo.jpg
"Over the last several years, the cold chain logistics market for clinical
trials has shown a growth of about 10%. This is largely related to the
increasing number of biologicals and monoclonal antibodies that are under
study. Therefore, cold chain failure in clinical trials has an increasing
impact," says Dr. Harald van Weeren (https://c212.net/c/link/?t=0&l=en&o=3314794-1&h=4112669640&u=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fharald-van-weeren-b574524%2F&a=Harald+van+Weeren), Segment Manager Clinical Trials at Berlinger.
Our organizations understand the risks of managing temperature-controlled IMP,
and therefore, we focused on designing a solution to help reduce risk and
eliminate the core issues. Such problems include limited transparency and
missing information, the lack of immediate centralized visibility,
time-consuming excursion management and slow decision making, time-consuming
data consolidation for audits, wastage of drugs, and patient rescheduling or
lost.
Through this partnership, endpoint and Berlinger can provide Sponsors with a
fully integrated solution, taking a 25-day manual temperature-monitoring data
evaluation and turning it into instant decision making. This drastically
reduces costs up to 7-digit figures and improves patient safety, allowing for
fast decision-making through complete visibility of the temperature history.
Sponsors and sites will reap immediate benefits through this sophisticated
technology integration in a variety of areas:
-- Education: Less instruction needed for the site users
-- Handling: A reduction in admin time, manual handling, and associated
risks
-- Excursion Management: Reduce the risk for dispensing drugs affected by a
temperature deviation
-- Patient: Reduce failed patient visits and increase patient safety
-- Audit: All of the temperature data available in one system for easy
preparation
-- Drugs: Reduce waste of trial products
"Patient safety has always been a high priority for endpoint. As cold chain
logistics become increasingly important due to the ever-growing number of
studies that work with biologics, we understand how vital it is to maintain the
chain of custody. This ensures that IMP does not go outside of agreed
temperature ranges for that product. We are happy to be partnering with
Berlinger on an integration providing a seamless solution for both the sponsor
and site," says Jeff Rubesin (https://c212.net/c/link/?t=0&l=en&o=3314794-1&h=4061748291&u=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fjeff-rubesin-618831b%2F&a=Jeff+Rubesin), Senior Director, Product Strategy at endpoint Clinical.
About endpoint
endpoint is an interactive response technology (IRT(R)) systems and solutions
provider that supports the life sciences industry. For the past decade, their
customer-obsessed team of professionals has been continuously evolving their
suite of technologies to help Sponsors achieve clinical trial success. Their
dynamic IRT solution, PULSE(R), for patient randomization and management, site
management, and drug supply management and leading-edge clinical supplies
management tool, DRIVE, has proven to maximize the supply chain and minimize
operational costs, and ensure timely and accurate patient dosing. endpoint is
headquartered in San Francisco, California, with offices across the US, EU, and
Asia. www.endpointclinical.com
About Berlinger
Berlinger is a traditional and independent Swiss and family-owned company that
is specialized in the production of innovative and customized solutions for
monitoring temperature-sensitive goods in the pharmaceutical and medical
industry as well as for doping control equipment to ensure safe transportation
and storage of urine and blood samples in the sports industry.
Established in 1865 as a weaving manufacturer, Berlinger has developed its
business over the years and has become a world-leading manufacturer of Doping
Control Equipment and is among the top three leaders in the market of
temperature monitoring solutions.
Visit https://www.berlinger.com/usa/ to learn more.
Contacts:
Monica Holt
Marketing Communications Manager
endpoint Clinical
e: mholt@endpointclinical.com
Barbara Hoefelmayr
Marketing Manager
Berlinger
+41 71 982 86 02
e: barbara.hoefelmayr@berlinger.com
SOURCE: endpoint Clinical
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。